Investment into molecular diagnostics company makes perfect Sense
Mercia Fund Management (Mercia) has underlined its commitment to pursue investment in the burgeoning diagnostics sector by investing early stage capital in Sense Biodetection Limited (Sense). The investment will allow Sense to develop its initial product – point-of-care diagnostic tests within the infectious diseases market. Experienced angel investor and former CEO of the Bank of